Cite
HARVARD Citation
Felten, R. et al. (2022). B-cell targeted therapy is associated with severe COVID-19 among patients with inflammatory arthritides: a 1-year multicentre study in 1116 successive patients receiving intravenous biologics. Annals of the rheumatic diseases. 81 (1), pp. 143-145. [Online].